- Home
- BDRX vs SNES Comparison
BDRX vs SNES Comparison
Compare BDRX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- SNES
- Stock Information
- Founded
- BDRX 2000
- SNES 2004
- Country
- BDRX United Kingdom
- SNES United States
- Employees
- BDRX N/A
- SNES N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- BDRX Health Care
- SNES Industrials
- Exchange
- BDRX Nasdaq
- SNES Nasdaq
- Market Cap
- BDRX 2.4M
- SNES 2.3M
- IPO Year
- BDRX N/A
- SNES 2016
- Fundamental
- Price
- BDRX $4.28
- SNES $2.80
- Analyst Decision
- BDRX Strong Buy
- SNES Strong Buy
- Analyst Count
- BDRX 1
- SNES 1
- Target Price
- BDRX $200.00
- SNES $10.00
- AVG Volume (30 Days)
- BDRX 16.1K
- SNES 50.7K
- Earning Date
- BDRX 09-30-2024
- SNES 02-19-2025
- Dividend Yield
- BDRX N/A
- SNES N/A
- EPS Growth
- BDRX N/A
- SNES N/A
- EPS
- BDRX N/A
- SNES N/A
- Revenue
- BDRX $104,895.00
- SNES $1,651,000.00
- Revenue This Year
- BDRX N/A
- SNES $76.36
- Revenue Next Year
- BDRX N/A
- SNES $103.47
- P/E Ratio
- BDRX N/A
- SNES N/A
- Revenue Growth
- BDRX N/A
- SNES 38.16
- 52 Week Low
- BDRX $3.50
- SNES $1.90
- 52 Week High
- BDRX $74.00
- SNES $13.30
- Technical
- Relative Strength Index (RSI)
- BDRX 47.13
- SNES 44.04
- Support Level
- BDRX $4.13
- SNES $2.97
- Resistance Level
- BDRX $4.60
- SNES $3.20
- Average True Range (ATR)
- BDRX 0.25
- SNES 0.29
- MACD
- BDRX 0.04
- SNES -0.07
- Stochastic Oscillator
- BDRX 55.15
- SNES 9.99
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.